Skip to content

Clinical trials

Pulmonary Fibrosis trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Fibrosis Country / region: United States Clear all

128 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20021
20035
20042
20052
20063
20074
20087
20092
20107
20118
20137
20143
20151
20163
20174
20186
20192
20209
202111
20229
20236
20244
20258
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed55
Recruiting22
Terminated21
Active, not recruiting11
Unknown status10
Enrolling by invitation3
Withdrawn3
Not yet recruiting2
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Heart, Lung, and Blood Institute (NHLBI)9
National Jewish Health6
National Human Genome Research Institute (NHGRI)5
Bristol-Myers Squibb4
Kyntra Bio4
Boehringer Ingelheim3
Celgene3
Duke University3
InterMune3
Mayo Clinic3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Fibrosis128
Idiopathic Pulmonary Fibrosis54
Lung Diseases, Interstitial42
Lung Diseases18
Fibrosis14
Hypertension, Pulmonary12
Pulmonary Disease, Chronic Obstructive12
Idiopathic Interstitial Pneumonias10
Sarcoidosis10
Emphysema7

Trials

Showing 1 to 25 of 128. Each trial links to its page on Pharma Observatory.

28 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.